"'It works fantastically... in conjunction with a cloud-based AP LIS, [XIFIN LIS Anywhere formerly] called PathCentral'... 'its fidelity is enhanced via programming services that can be automated in the EHR and AP LIS,' he adds...A lab technician will verify the information in the AP LIS, and 'the accessioning process is reduced from two to three minutes per case to five to 10 seconds.'...'This makes it possible for us to plan our personnel for increased specimen loads and makes us immediately aware of specimens that haven’t arrived in pathology,'....The process will continue beyond accessioning, 'to track all specimen containers to gross benches where cassettes are printed on demand, into and through histology processing, and ultimately to the pathologist to whom cases are assigned.' Once complete, they will be scanned into archives."
"My group and I have never looked back in the 6 years since we made our professional home in the cloud. In fact, at meetings when I hear colleagues discussing the inflexibility and cost of their traditional LIS systems, I confess with a measure of guilt that I feel like a Tesla driver listening to the problems of horse-drawn carriage drivers."
"Before XIFIN, things that were going into bad debt were both contractual adjustments as well as true bad debt. Now, we have a better indicator from a financial statement perspective how we're really performing and it's been a huge advantage to us."
"Implementing RCM solutions that will help us navigate the reimbursement and regulatory complexities of the molecular diagnostics market is critical to drive rapid company growth. XIFIN was the clear choice because the company has a solid reputation for achieving results, powerful web service technology, and a leadership team recognized for change advocacy and reform in the molecular DX and diagnostic services market. I am confident that our partnership with XIFIN will provide the framework we need to strategically manage our operations and drive growth and profitability."
"We've seen a 35% improvement in our cash collections over the short two year period that we've had the XIFIN product up and running and validated. It's been a very important tool for us to really improve the financial health of our company."
"Given the complexity of healthcare billing, especially in the lab industry, SaaS will help us leverage external expertise without replicating resources in house. By utilizing the rules-based engines inherent in the XIFIN software, we will see efficiencies in our process, improvements in our reimbursement and revenue cycle, plus enhancements in our reporting capabilities. With these improvements, we expect to see an immediate return on our SaaS expenditures."